Oncogenic effects of exosomes in γ‐herpesvirus‐associated neoplasms

Kaposi's sarcoma‐associated herpesvirus (KSHV) and Epstein–Barr virus (EBV) are herpesviruses associated with human malignancies. As exosomes can shuttle many herpesvirus‐associated biomolecules from host cells to recipient cells, the exosomal pathway is utilized by herpesviruses to achieve ext...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular physiology Vol. 234; no. 11; pp. 19167 - 19179
Main Authors Zheng, Jiayu, Shi, Yiwan, Feng, Zhenyu, Zheng, Yilu, Li, Zhanhao, Zhao, Yi, Wang, Yan
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.11.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Kaposi's sarcoma‐associated herpesvirus (KSHV) and Epstein–Barr virus (EBV) are herpesviruses associated with human malignancies. As exosomes can shuttle many herpesvirus‐associated biomolecules from host cells to recipient cells, the exosomal pathway is utilized by herpesviruses to achieve extensive infections and even oncogenesis. In this review, we discuss the oncogenic biomolecules present in exosomes derived from KSHV‐ and EBV‐infected cells. Moreover, oncogenesis via exosomal biomolecules mainly occurs through three processes, including regulation of downstream signals, promotion of immune dysfunction and transformation of cells. Also, the exosomes may provide diagnostic markers and therapeutic targets specific for KSHV‐ and EBV‐associated malignancies. Kaposi's sarcoma‐associated herpesvirus (KSHV)‐ and Epstein–Barr virus (EBV)‐associated exosomes manipulate the extracellular environment leading to neoplasm progression. Regulation of downstream signals, promotion of immune dysfunction and transformation of cells are three major bioeffects of KSHV‐ and EBV‐associated exosomes.
AbstractList Kaposi's sarcoma‐associated herpesvirus (KSHV) and Epstein–Barr virus (EBV) are herpesviruses associated with human malignancies. As exosomes can shuttle many herpesvirus‐associated biomolecules from host cells to recipient cells, the exosomal pathway is utilized by herpesviruses to achieve extensive infections and even oncogenesis. In this review, we discuss the oncogenic biomolecules present in exosomes derived from KSHV‐ and EBV‐infected cells. Moreover, oncogenesis via exosomal biomolecules mainly occurs through three processes, including regulation of downstream signals, promotion of immune dysfunction and transformation of cells. Also, the exosomes may provide diagnostic markers and therapeutic targets specific for KSHV‐ and EBV‐associated malignancies. Kaposi's sarcoma‐associated herpesvirus (KSHV)‐ and Epstein–Barr virus (EBV)‐associated exosomes manipulate the extracellular environment leading to neoplasm progression. Regulation of downstream signals, promotion of immune dysfunction and transformation of cells are three major bioeffects of KSHV‐ and EBV‐associated exosomes.
Kaposi's sarcoma‐associated herpesvirus (KSHV) and Epstein–Barr virus (EBV) are herpesviruses associated with human malignancies. As exosomes can shuttle many herpesvirus‐associated biomolecules from host cells to recipient cells, the exosomal pathway is utilized by herpesviruses to achieve extensive infections and even oncogenesis. In this review, we discuss the oncogenic biomolecules present in exosomes derived from KSHV‐ and EBV‐infected cells. Moreover, oncogenesis via exosomal biomolecules mainly occurs through three processes, including regulation of downstream signals, promotion of immune dysfunction and transformation of cells. Also, the exosomes may provide diagnostic markers and therapeutic targets specific for KSHV‐ and EBV‐associated malignancies.
Abstract Kaposi's sarcoma‐associated herpesvirus (KSHV) and Epstein–Barr virus (EBV) are herpesviruses associated with human malignancies. As exosomes can shuttle many herpesvirus‐associated biomolecules from host cells to recipient cells, the exosomal pathway is utilized by herpesviruses to achieve extensive infections and even oncogenesis. In this review, we discuss the oncogenic biomolecules present in exosomes derived from KSHV‐ and EBV‐infected cells. Moreover, oncogenesis via exosomal biomolecules mainly occurs through three processes, including regulation of downstream signals, promotion of immune dysfunction and transformation of cells. Also, the exosomes may provide diagnostic markers and therapeutic targets specific for KSHV‐ and EBV‐associated malignancies.
Author Shi, Yiwan
Zheng, Jiayu
Feng, Zhenyu
Zhao, Yi
Li, Zhanhao
Zheng, Yilu
Wang, Yan
Author_xml – sequence: 1
  givenname: Jiayu
  orcidid: 0000-0001-7640-4827
  surname: Zheng
  fullname: Zheng, Jiayu
  organization: Guangdong Medical University
– sequence: 2
  givenname: Yiwan
  surname: Shi
  fullname: Shi, Yiwan
  organization: Guangdong Medical University
– sequence: 3
  givenname: Zhenyu
  surname: Feng
  fullname: Feng, Zhenyu
  organization: Guangdong Medical University
– sequence: 4
  givenname: Yilu
  surname: Zheng
  fullname: Zheng, Yilu
  organization: Guangdong Medical University
– sequence: 5
  givenname: Zhanhao
  surname: Li
  fullname: Li, Zhanhao
  organization: Guangdong Medical University
– sequence: 6
  givenname: Yi
  surname: Zhao
  fullname: Zhao, Yi
  email: zhaoyicomnet@gdmu.edu.cn
  organization: Guangdong Medical University
– sequence: 7
  givenname: Yan
  surname: Wang
  fullname: Wang, Yan
  email: wangyan29@gdmu.edu.cn
  organization: Guangdong Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30941765$$D View this record in MEDLINE/PubMed
BookMark eNp10DtOxDAQBmALgWBZKLgAikQDRRa_4sQlWvEUEhRQR44zhqySOGQ2PDqOwF24B4fgJBgWKJCoRtZ8-j3618ly61sgZIvRCaOU789sN-FZkoolMmJUp7FUCV8mo7BjsU4kWyPriDNKqdZCrJI1QbVkqUpG5OSitf4G2spG4BzYOUbeRfDo0TeAUdVGb6_vzy-30HeA91U_YHgZRG8rM4cyasF3tcEGN8iKMzXC5vcck-ujw6vpSXx-cXw6PTiPrQh_x0CddioxhaOFAm7BsMTwMrWlppmDTHKQhUwTozIptHU0k-CMKxKnIFWlE2Oyu8jten83AM7zpkILdW3CKQPmnFOuUi25CHTnD535oW_DdUEpwZSSVAa1t1C294g9uLzrq8b0Tzmj-We9eag3_6o32O3vxKFooPyVP30GsL8AD1UNT_8n5WfTy0XkB4DqiR4
CitedBy_id crossref_primary_10_3389_fnano_2022_987034
crossref_primary_10_3390_v12040429
crossref_primary_10_1088_1748_605X_abaaa2
crossref_primary_10_1016_j_ejca_2023_01_010
crossref_primary_10_1186_s13027_022_00471_x
crossref_primary_10_3389_fcimb_2020_593170
crossref_primary_10_3390_cancers15030855
crossref_primary_10_47184_tev_2020_01_02
crossref_primary_10_1080_23744235_2022_2149852
crossref_primary_10_3389_fmicb_2020_604536
crossref_primary_10_3390_v12060623
Cites_doi 10.1038/cddis.2015.151
10.1016/S2214‐109X(16)30143‐7
10.1158/0008‐5472.CAN‐04‐0733
10.1093/jnci/dju363
10.1002/adhm.201801268
10.1002/hon.2360
10.1371/journal.pone.0099163
10.1126/science.1096781
10.1073/pnas.0804543106
10.1016/j.devcel.2011.08.019
10.3410/B3‐15
10.1128/JVI.01997‐09
10.1038/ncb1929
10.1016/j.semcancer.2008.10.004
10.14503/THIJ‐14‐4254
10.1016/j.tibs.2015.12.001
10.1038/ncb1596
10.4161/cc.9.17.12731
10.1172/JCI40567
10.1016/j.tim.2017.02.002
10.1002/ijc.22844
10.1126/science.7997879
10.4049/jimmunol.1200312
10.1128/JVI.03282‐12
10.1001/jamaoncol.2016.0097
10.1073/pnas.0914843107
10.3390/v6104005
10.1016/S0966-842X(99)01605-4
10.1128/JVI.01147‐12
10.3390/v8060156
10.1371/journal.pone.0169290
10.1126/science.1153124
10.1128/mSphere.00030‐18
10.1371/journal.ppat.1006524
10.1007/978-1-4939-0859-2_5
10.1016/j.canlet.2013.05.012
10.1038/mt.2009.41
10.7150/ijbs.24562
10.1371/journal.ppat.1003484
10.3389/fonc.2018.00265
10.1073/pnas.1303906110
10.1128/JVI.02251‐16
10.18632/oncotarget.16996
10.1002/rmv.1763
10.1128/JVI.00202‐10
10.1073/pnas.1014194107
10.1016/j.chom.2009.11.008
10.1177/002215540205000105
10.1016/j.chom.2009.03.003
10.1093/emboj/19.24.6742
10.1182/blood‐2008‐02‐142596
10.1016/j.devcel.2011.05.015
10.1128/JVI.00884‐10
10.2478/s11658‐008‐0045‐2
10.4161/isl.2.5.13095
10.1038/ncomms13588
10.1016/j.virol.2006.10.046
10.1186/s12985‐015‐0441‐y
10.1371/journal.pone.0162574
10.1128/JVI.75.8.4008‐4013.2001
10.1038/s41590‐017‐0043‐5
10.1038/sj.onc.1208357
10.4049/jimmunol.165.2.663
10.1080/17474086.2017.1326815
10.1186/1471‐2407‐6‐283
10.1099/jgv.0.000313
10.1016/S0140‐6736(02)09552‐1
10.1042/BST0381413
10.1158/1078‐0432.CCR‐06‐2945
10.1038/nature07961
10.1038/onc.2014.66
10.1016/S0021-9258(18)48095-7
10.1016/j.pharmthera.2017.02.020
10.1038/emboj.2011.286
10.3389/fimmu.2014.00144
10.1111/j.1600‐0714.2006.00394.x
10.18632/oncotarget.21668
10.1371/journal.pone.0016224
10.3390/mi9070340
10.1038/mt.2012.180
10.1128/JVI.01310‐13
ContentType Journal Article
Copyright 2019 Wiley Periodicals, Inc.
Copyright_xml – notice: 2019 Wiley Periodicals, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
7U7
8FD
C1K
FR3
K9.
P64
RC3
7X8
DOI 10.1002/jcp.28573
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Technology Research Database
Toxicology Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
Genetics Abstracts
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
EISSN 1097-4652
EndPage 19179
ExternalDocumentID 10_1002_jcp_28573
30941765
JCP28573
Genre reviewArticle
Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Research Foundation Project of Guangdong Medical University
  funderid: Z2015004
– fundername: Chinese Medicine Research Foundation of Guangdong Province
  funderid: 20161141
– fundername: Science and Technology Planning Project of Dongguan City
  funderid: 2016108101028
– fundername: National Training Program of Innovation and Entrepreneurship for Undergraduates
  funderid: 201810571018
– fundername: Innovative Experimental Project for Guangdong Medical University students
  funderid: 2017ZYDS006; 2017ZYDS005
– fundername: Natural Science Foundation of Guangdong Province
  funderid: 2016A030313674; 2015A030310046
– fundername: Science and Technology Planning Project of Guangdong Province
  funderid: 2016A020215224; Z2015004
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
9M8
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABPPZ
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AETEA
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BQCPF
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMB
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
G8K
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
H~9
IH2
IX1
J0M
JPC
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M56
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MVM
MXFUL
MXSTM
N04
N05
N9A
NEJ
NF~
NNB
O66
O9-
OHT
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RWR
RX1
RYL
S10
SAMSI
SUPJJ
SV3
TN5
TWZ
UB1
UPT
V2E
V8K
VQP
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYB
WYISQ
X7M
XG1
XJT
XOL
XPP
XSW
XV2
Y6R
YQT
YZZ
ZGI
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ABDPE
CITATION
7TK
7U7
8FD
C1K
FR3
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3933-e0f9f65abf0b6e2cea15a2d7cd908fe842e4b475a68439cf084efafb5f6e76df3
IEDL.DBID DR2
ISSN 0021-9541
IngestDate Fri Aug 16 08:07:27 EDT 2024
Sun Nov 10 04:59:35 EST 2024
Mon Nov 04 10:09:31 EST 2024
Sat Sep 28 08:28:16 EDT 2024
Sat Aug 24 01:11:43 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords EBV
neoplasms
KSHV
exosome
Language English
License 2019 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3933-e0f9f65abf0b6e2cea15a2d7cd908fe842e4b475a68439cf084efafb5f6e76df3
Notes Zheng and Shi have contributed equally to this study.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0001-7640-4827
PMID 30941765
PQID 2263166404
PQPubID 1006363
PageCount 13
ParticipantIDs proquest_miscellaneous_2202679423
proquest_journals_2263166404
crossref_primary_10_1002_jcp_28573
pubmed_primary_30941765
wiley_primary_10_1002_jcp_28573_JCP28573
PublicationCentury 2000
PublicationDate November 2019
2019-11-00
20191101
PublicationDateYYYYMMDD 2019-11-01
PublicationDate_xml – month: 11
  year: 2019
  text: November 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of cellular physiology
PublicationTitleAlternate J Cell Physiol
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_10_1_27_1
e_1_2_10_1_29_1
e_1_2_10_1_23_1
e_1_2_10_1_46_1
e_1_2_10_1_69_1
e_1_2_10_1_25_1
e_1_2_10_1_48_1
e_1_2_10_1_67_1
e_1_2_10_1_42_1
e_1_2_10_1_65_1
e_1_2_10_1_21_1
e_1_2_10_1_44_1
e_1_2_10_1_63_1
e_1_2_10_1_61_1
e_1_2_10_1_40_1
e_1_2_10_1_82_1
e_1_2_10_1_80_1
e_1_2_10_1_9_1
e_1_2_10_1_7_1
e_1_2_10_1_16_1
e_1_2_10_1_39_1
e_1_2_10_1_18_1
e_1_2_10_1_12_1
e_1_2_10_1_35_1
e_1_2_10_1_58_1
e_1_2_10_1_14_1
e_1_2_10_1_37_1
e_1_2_10_1_56_1
e_1_2_10_1_79_1
e_1_2_10_1_31_1
e_1_2_10_1_5_1
e_1_2_10_1_52_1
e_1_2_10_1_77_1
e_1_2_10_1_10_1
e_1_2_10_1_33_1
e_1_2_10_1_3_1
e_1_2_10_1_54_1
e_1_2_10_1_75_1
e_1_2_10_1_73_1
e_1_2_10_1_50_1
e_1_2_10_1_28_1
e_1_2_10_1_49_1
e_1_2_10_1_24_1
e_1_2_10_1_45_1
e_1_2_10_1_26_1
e_1_2_10_1_47_1
e_1_2_10_1_68_1
e_1_2_10_1_20_1
e_1_2_10_1_41_1
e_1_2_10_1_66_1
Riva G. (e_1_2_10_1_71_1) 2010; 12
e_1_2_10_1_22_1
e_1_2_10_1_43_1
e_1_2_10_1_64_1
e_1_2_10_1_62_1
e_1_2_10_1_83_1
e_1_2_10_1_60_1
e_1_2_10_1_81_1
e_1_2_10_1_8_1
e_1_2_10_1_17_1
e_1_2_10_1_38_1
e_1_2_10_1_19_1
e_1_2_10_1_2_1
e_1_2_10_1_13_1
e_1_2_10_1_34_1
e_1_2_10_1_59_1
e_1_2_10_1_78_1
e_1_2_10_1_15_1
e_1_2_10_1_36_1
e_1_2_10_1_57_1
e_1_2_10_1_6_1
e_1_2_10_1_53_1
e_1_2_10_1_76_1
e_1_2_10_1_30_1
e_1_2_10_1_4_1
e_1_2_10_1_55_1
e_1_2_10_1_74_1
e_1_2_10_1_11_1
e_1_2_10_1_32_1
e_1_2_10_1_72_1
e_1_2_10_1_51_1
e_1_2_10_1_70_1
References_xml – ident: e_1_2_10_1_29_1
  doi: 10.1038/cddis.2015.151
– ident: e_1_2_10_1_67_1
  doi: 10.1016/S2214‐109X(16)30143‐7
– ident: e_1_2_10_1_82_1
  doi: 10.1158/0008‐5472.CAN‐04‐0733
– ident: e_1_2_10_1_57_1
  doi: 10.1093/jnci/dju363
– ident: e_1_2_10_1_21_1
  doi: 10.1002/adhm.201801268
– ident: e_1_2_10_1_46_1
  doi: 10.1002/hon.2360
– ident: e_1_2_10_1_7_1
  doi: 10.1371/journal.pone.0099163
– ident: e_1_2_10_1_64_1
  doi: 10.1126/science.1096781
– ident: e_1_2_10_1_8_1
  doi: 10.1073/pnas.0804543106
– ident: e_1_2_10_1_60_1
  doi: 10.1016/j.devcel.2011.08.019
– ident: e_1_2_10_1_76_1
  doi: 10.3410/B3‐15
– ident: e_1_2_10_1_49_1
  doi: 10.1128/JVI.01997‐09
– ident: e_1_2_10_1_25_1
  doi: 10.1038/ncb1929
– ident: e_1_2_10_1_54_1
  doi: 10.1016/j.semcancer.2008.10.004
– ident: e_1_2_10_1_74_1
  doi: 10.14503/THIJ‐14‐4254
– ident: e_1_2_10_1_47_1
  doi: 10.1016/j.tibs.2015.12.001
– ident: e_1_2_10_1_78_1
  doi: 10.1038/ncb1596
– ident: e_1_2_10_1_13_1
  doi: 10.4161/cc.9.17.12731
– ident: e_1_2_10_1_22_1
  doi: 10.1172/JCI40567
– ident: e_1_2_10_1_68_1
  doi: 10.1016/j.tim.2017.02.002
– ident: e_1_2_10_1_15_1
  doi: 10.1002/ijc.22844
– ident: e_1_2_10_1_16_1
  doi: 10.1126/science.7997879
– ident: e_1_2_10_1_30_1
  doi: 10.4049/jimmunol.1200312
– ident: e_1_2_10_1_75_1
  doi: 10.1128/JVI.03282‐12
– ident: e_1_2_10_1_51_1
  doi: 10.1001/jamaoncol.2016.0097
– ident: e_1_2_10_1_63_1
  doi: 10.1073/pnas.0914843107
– ident: e_1_2_10_1_66_1
  doi: 10.3390/v6104005
– ident: e_1_2_10_1_55_1
  doi: 10.1016/S0966-842X(99)01605-4
– ident: e_1_2_10_1_2_1
  doi: 10.1128/JVI.01147‐12
– ident: e_1_2_10_1_65_1
  doi: 10.3390/v8060156
– ident: e_1_2_10_1_10_1
  doi: 10.1371/journal.pone.0169290
– ident: e_1_2_10_1_77_1
  doi: 10.1126/science.1153124
– ident: e_1_2_10_1_45_1
  doi: 10.1128/mSphere.00030‐18
– ident: e_1_2_10_1_83_1
  doi: 10.1371/journal.ppat.1006524
– ident: e_1_2_10_1_18_1
  doi: 10.1007/978-1-4939-0859-2_5
– ident: e_1_2_10_1_14_1
  doi: 10.1016/j.canlet.2013.05.012
– ident: e_1_2_10_1_73_1
  doi: 10.1038/mt.2009.41
– ident: e_1_2_10_1_81_1
  doi: 10.7150/ijbs.24562
– ident: e_1_2_10_1_17_1
  doi: 10.1371/journal.ppat.1003484
– ident: e_1_2_10_1_20_1
  doi: 10.3389/fonc.2018.00265
– ident: e_1_2_10_1_53_1
  doi: 10.1073/pnas.1303906110
– ident: e_1_2_10_1_35_1
  doi: 10.1128/JVI.02251‐16
– ident: e_1_2_10_1_72_1
  doi: 10.18632/oncotarget.16996
– ident: e_1_2_10_1_5_1
  doi: 10.1002/rmv.1763
– ident: e_1_2_10_1_28_1
  doi: 10.1128/JVI.00202‐10
– ident: e_1_2_10_1_52_1
  doi: 10.1073/pnas.1014194107
– ident: e_1_2_10_1_12_1
  doi: 10.1016/j.chom.2009.11.008
– ident: e_1_2_10_1_56_1
  doi: 10.1177/002215540205000105
– ident: e_1_2_10_1_58_1
  doi: 10.1016/j.chom.2009.03.003
– ident: e_1_2_10_1_42_1
  doi: 10.1093/emboj/19.24.6742
– ident: e_1_2_10_1_43_1
  doi: 10.1182/blood‐2008‐02‐142596
– ident: e_1_2_10_1_31_1
  doi: 10.1016/j.devcel.2011.05.015
– ident: e_1_2_10_1_3_1
  doi: 10.1128/JVI.00884‐10
– volume: 12
  start-page: 40
  issue: 1
  year: 2010
  ident: e_1_2_10_1_71_1
  article-title: Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma‐associated herpesvirus/human herpesvirus 8‐associated neoplasias
  publication-title: AIDS Reviews
  contributor:
    fullname: Riva G.
– ident: e_1_2_10_1_62_1
  doi: 10.2478/s11658‐008‐0045‐2
– ident: e_1_2_10_1_79_1
  doi: 10.4161/isl.2.5.13095
– ident: e_1_2_10_1_80_1
  doi: 10.1038/ncomms13588
– ident: e_1_2_10_1_37_1
  doi: 10.1016/j.virol.2006.10.046
– ident: e_1_2_10_1_23_1
  doi: 10.1186/s12985‐015‐0441‐y
– ident: e_1_2_10_1_32_1
  doi: 10.1371/journal.pone.0162574
– ident: e_1_2_10_1_27_1
  doi: 10.1128/JVI.75.8.4008‐4013.2001
– ident: e_1_2_10_1_24_1
  doi: 10.1038/s41590‐017‐0043‐5
– ident: e_1_2_10_1_38_1
  doi: 10.1038/sj.onc.1208357
– ident: e_1_2_10_1_19_1
  doi: 10.4049/jimmunol.165.2.663
– ident: e_1_2_10_1_26_1
  doi: 10.1080/17474086.2017.1326815
– ident: e_1_2_10_1_41_1
  doi: 10.1186/1471‐2407‐6‐283
– ident: e_1_2_10_1_6_1
  doi: 10.1099/jgv.0.000313
– ident: e_1_2_10_1_9_1
  doi: 10.1016/S0140‐6736(02)09552‐1
– ident: e_1_2_10_1_50_1
  doi: 10.1042/BST0381413
– ident: e_1_2_10_1_33_1
  doi: 10.1158/1078‐0432.CCR‐06‐2945
– ident: e_1_2_10_1_69_1
  doi: 10.1038/nature07961
– ident: e_1_2_10_1_4_1
  doi: 10.1038/onc.2014.66
– ident: e_1_2_10_1_40_1
  doi: 10.1016/S0021-9258(18)48095-7
– ident: e_1_2_10_1_11_1
  doi: 10.1016/j.pharmthera.2017.02.020
– ident: e_1_2_10_1_34_1
  doi: 10.1038/emboj.2011.286
– ident: e_1_2_10_1_44_1
  doi: 10.3389/fimmu.2014.00144
– ident: e_1_2_10_1_70_1
  doi: 10.1111/j.1600‐0714.2006.00394.x
– ident: e_1_2_10_1_39_1
  doi: 10.18632/oncotarget.21668
– ident: e_1_2_10_1_48_1
  doi: 10.1371/journal.pone.0016224
– ident: e_1_2_10_1_36_1
  doi: 10.3390/mi9070340
– ident: e_1_2_10_1_61_1
  doi: 10.1038/mt.2012.180
– ident: e_1_2_10_1_59_1
  doi: 10.1128/JVI.01310‐13
SSID ssj0009933
Score 2.4062192
SecondaryResourceType review_article
Snippet Kaposi's sarcoma‐associated herpesvirus (KSHV) and Epstein–Barr virus (EBV) are herpesviruses associated with human malignancies. As exosomes can shuttle many...
Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) are herpesviruses associated with human malignancies. As exosomes can shuttle many...
Abstract Kaposi's sarcoma‐associated herpesvirus (KSHV) and Epstein–Barr virus (EBV) are herpesviruses associated with human malignancies. As exosomes can...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 19167
SubjectTerms Biomolecules
Carcinogenesis - genetics
Cell Transformation, Neoplastic - genetics
Diagnostic systems
EBV
Epstein-Barr virus
exosome
Exosomes
Exosomes - genetics
Exosomes - virology
Herpes viruses
Herpesvirus 4, Human - genetics
Herpesvirus 4, Human - pathogenicity
Herpesvirus 8, Human - genetics
Herpesvirus 8, Human - pathogenicity
Humans
Kaposi's sarcoma
KSHV
Neoplasms
Neoplasms - genetics
Neoplasms - pathology
Neoplasms - virology
Sarcoma
Signal processing
Therapeutic applications
Tumorigenesis
Viruses
Title Oncogenic effects of exosomes in γ‐herpesvirus‐associated neoplasms
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.28573
https://www.ncbi.nlm.nih.gov/pubmed/30941765
https://www.proquest.com/docview/2263166404
https://search.proquest.com/docview/2202679423
Volume 234
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB5KQfDFS-slWmUVEV9ymsteEnwq1XIoeEEs9EEIu5tZOJWTHJpzSuuTP8H_4v_wR_hLnN0kp1QRxLeEbNjszkzm29nZbwCe1TzPyS-JGEVpYi6NjrVVMhYKTZ0iGhMCbm_eyukRPzwWxxvwcjwL0_NDrANu3jLC_9obuDbd7iVp6IldTLJCKM_0mebKp3O9-nBJHVUOZeRDCoLg6cgqlGS76zev-qI_AOZVvBoczsFN-DR-ap9n8nmyWpqJ_fIbi-N_juUW3BiAKNvrNec2bGCzBdt7DS3C5xfsOQupoSHmvgXX-oqVF9swfdfYlnRuZtmQCcJax_C87do5dmzWsB_ff379RoqwwO5sdrrq6E4PKoA1a3zCuu7m3R04Onj9cX8aD8UYYpvTVMaYuNJJoY1LjMTMok6Fzmpl6zIpHBY8Q264EloWhHGsSwqOTjsjnEQla5ffhc2mbfA-MFsaW2TOSs0Vd8ZTkOkyI60gv6ExdRE8HcVSLXrOjapnV84qmqkqzFQEO6PAqsHsuoqwZJ5KyRMewZP1YzIYvwuiaYgr38YX3SoJRkZwrxf0upecFrupkiKCF0Fcf---Otx_Hy4e_HvTh3Cd4FbZn2Tcgc3l6QofEaRZmsdBd38BGUP13Q
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VIgQXflp-AgUMQohLtvmxnUTiUhWqpbQFoVbqBUW2M5YWtMmq2UWUE4_Au_AePARPwthJtioICXFLFEeOPTOZz-PxNwBPKp6m5JdEiKLQIZdahcpkMhQZ6ipG1NoH3PYP5PiI7x6L4xV4PpyF6fghlgE3Zxn-f-0M3AWkN89YQz-Y2SjJRZZegItk7qkr3PDi3Rl5VNEXkvdJCILHA69QlGwuXz3vjf6AmOcRq3c5O9fg_fCxXabJx9Firkfmy288jv87mutwtceibKtTnhuwgvUarG_VtA6fnrKnzGeH-rD7GlzqilaersP4TW0aUruJYX0yCGssw89N20yxZZOa_fj-8-s30oUZtp8mJ4uW7lSvBVix2uWsq3ba3oSjnZeH2-Owr8cQmpTmMsTIFlYKpW2kJSYGVSxUUmWmKqLcYs4T5JpnQsmcYI6xUc7RKquFlZjJyqa3YLVuarwDzBTa5Ik1UvGMW-1YyFSRkGKQ61AY2wAeD3IpZx3tRtkRLCclzVTpZyqAjUFiZW95bUlwMo2l5BEP4NHyMdmM2whRNMSFa-PqbhWEJAO43Ul62UtK6904kyKAZ15ef---3N1-6y_u_nvTh3B5fLi_V-69Onh9D64Q-iq6g40bsDo_WeB9Qjhz_cAr8i9bAPn1
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VIhAXSlt-AoUahBCXbPNjO4k4VYXVtkCpEJV6QIpsZywtaJNVs4soJx6h79L36EPwJEycZKuCkFBvieLIsWcm83k8_gbgecHjmPyS8FFk2udSK1-ZRPoiQV2EiFq7gNv7fTk65HtH4mgJXvVnYVp-iEXArbEM979uDHxa2K0L0tAvZjqIUpHE1-A6l4R8G0T08YI7KuvqyLscBMHDnlYoiLYWr152Rn8hzMuA1Xmc4Qp87r-1TTT5OpjP9MD8-IPG8YqDuQO3OyTKtlvVWYUlLNdgfbukVfjkhL1gLjfUBd3X4EZbsvJkHUYfSlOR0o0N61JBWGUZfq_qaoI1G5fs_OzXz1PShCnW38bH85ruVKcDWLCyyVhX9aS-C4fDN592Rn5XjcE3MU2lj4HNrBRK20BLjAyqUKioSEyRBanFlEfINU-EkimBHGODlKNVVgsrMZGFje_BclmV-ACYybRJI2uk4gm3uuEgU1lEakGOQ2FoPXjWiyWftqQbeUuvHOU0U7mbKQ82eoHlnd3VOYHJOJSSB9yDp4vHZDHNNoiiIc6bNk3VrYxwpAf3W0EveolptRsmUnjw0onr393nezsH7uLh_zfdhJsHr4f5u939t4_gFkGvrD3VuAHLs-M5PiZ4M9NPnBr_BoLn-KQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oncogenic+effects+of+exosomes+in+%CE%B3-herpesvirus-associated+neoplasms&rft.jtitle=Journal+of+cellular+physiology&rft.au=Zheng%2C+Jiayu&rft.au=Shi%2C+Yiwan&rft.au=Feng%2C+Zhenyu&rft.au=Zheng%2C+Yilu&rft.date=2019-11-01&rft.eissn=1097-4652&rft.volume=234&rft.issue=11&rft.spage=19167&rft_id=info:doi/10.1002%2Fjcp.28573&rft_id=info%3Apmid%2F30941765&rft.externalDocID=30941765
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon